Skip to content
Subscribe
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Newsletter
Sujatha Gurunathan
Blog Post
FDA Approves argenx’s Vyvgart for Treatment of gMG
By
Sujatha Gurunathan
|
December 20, 2021
Blog Post
Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy
By
Sujatha Gurunathan
|
November 9, 2021
Blog Post
Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD
By
Sujatha Gurunathan
|
November 9, 2021
Blog Post
Muscular Dystrophy Association Awards 18 Grants Totaling Over $1.6 Million for Neuromuscular Disease Research
By
Sujatha Gurunathan
|
November 5, 2021
Blog Post
Research Study Alert: Observational Study of Clinical and Electrophysiological Outcomes in Adults with CMT
By
Sujatha Gurunathan
|
October 11, 2021
Blog Post
Clinical Trial Alert: Phase 3b Study of Oral Edaravone in Adults with ALS
By
Sujatha Gurunathan
|
October 11, 2021
Blog Post
Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD
By
Sujatha Gurunathan
|
September 30, 2021
Blog Post
FDA approves Octapharma’s Octagam® 10% for Treatment of Adults with Dermatomyositis
By
Sujatha Gurunathan
|
July 29, 2021
Blog Post
Biogen’s Early Access Program for Tofersen is Now Open for Individuals with Rapidly Progressing SOD1-ALS
By
Sujatha Gurunathan
|
July 6, 2021
Blog Post
FDA Approves Sarepta Therapeutics’ Amondys 45 for Treatment of DMD Amenable to Skipping Exon 45
By
Sujatha Gurunathan
|
February 25, 2021
« Previous
1
2
3
4
5
Next »
Skip to content
Open toolbar
Accessibility Tools
Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset